T. Rowe Price reports 111 shares of INC common stock
T. Rowe Price Investment Management, Inc. filed an amendment on Schedule 13G/A reporting beneficial ownership of 111 shares of common stock of INC (CUSIP 68278B107), representing 0.0% of the class.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
T. Rowe Price Investment Management, Inc. filed an amendment on Schedule 13G/A reporting beneficial ownership of 111 shares of common stock of INC (CUSIP 68278B107), representing 0.0% of the class. The filing states the holder owns sole voting and dispositive power over 111 shares and includes a formal denial of beneficial ownership. The filing is signed by Ellen York, Vice President, on 05/15/2026.
Insights
Small reported holding by an institutional manager; appears administrative.
The amendment lists 111 shares and 0.0% ownership, indicating a de minimis position in INC. The submission includes a formal statement denying beneficial ownership while disclosing voting and dispositive power.
Because the position is under 5 percent, this is routine reporting; subsequent filings would show any material change in stake.
Key Figures
Key Terms
Schedule 13G/A regulatory
Beneficial ownership financial
CUSIP regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Schedule 13G/A for OS show about T. Rowe Price's stake?
Does the Schedule 13G/A mean T. Rowe Price controls INC decisions (OS)?
When was the Schedule 13G/A for OS signed and by whom?
Is the reported OS ownership material under SEC thresholds?
AI-generated analysis. How Rhea-AI works. Not financial advice.